Sunscreen protection efficacy is quantified as the so-called sun protection factor (SPF), the ratio of minimal radiation dose for confluent erythema at 24 hours (minimal erythema dose, MED) on sunscreenprotected skin to that on unprotected skin. It is widely used to denote sunscreen efficacy, usually being between about 2 and 20, but somewhat dependent on skin sunscreen thickness6 7, method of sunscreen application7 and light source such as natural sunlight, fluorescent UV-B lamp or xenon arc solar simulator8"9. The divergence of experimental and real-life conditions reduces SPF usefulness, and a more realistic grouping into high, medium and low SPF categories has been proposed'0.
Sunscreen SPF depends on sp'ecific ingredients which either absorb WTVR and dissipate it as heat or else reflect it from the skin, and on preparation persistence after application, or substantivity". Absorbent sunscreen constituents include paraaminobenzoic acid (PABA), a UV-B filter which penetrates stratum corneum in 50-70% alcohol and resists washing'"; adverse effects are irritation and drying, particularly with chlorinated water , skin photosensitivity reactions3 and staining of fabric, all much less with amyl dimethyl, glyceryl and the water-resistant octyldimethyl PABA"6. Cinnamates, especially p-methoxy, absorb UV-B effectively, UV-A less, but do not resist washing unless in adherent vehicle; contact and photocontact dermatitis are possible'7" 8.. Benzophenones absorb UV-B fairly well but UV-A less", mexenone, sulisobenzone and oxybenzone with N,N-dimethyl-2-ethylhexyl PABA being effective, water-resistant20 and widely used, although contact sensitivity occurs21. Salicylates such as 10-15% homomenthyl salicylate are weak absorbers of UV-B, and anthranilates, especially menthyl and homomenthyl-N-acetyl, of UV-A22, both generally in combination with other agents23; contact dermatitis may develop with salicylates24. Camphor compounds such as 3-(4-methylbenzylidene)-dl-camphor 1-5% are UV-B absorbers used with benzophe-nones25; they are also used, as is methoxycinnamate, with the UV-A absorbing dibenzoylmethane derivatives, although these last may cause contact and photocontact dermatitis26. 2-phenyl-benzimidazole-5-sulphonic acid 2-5%, 2-phenyl-5-methylbenzoxazole 2-5%, sodium 3,4, dimethoxyphenylglyoxylate 2-4%, dibenzalazine and digalloyl trioleate are also used as UV-B screens in combination for broad protection; photocontact dermatitis occurs with the last of these27. Methoxypsoralen has been used in absorbent screens as a tanning accelerator, but enhances phototumorigenesis in mice28, though apparently not with UV-B filters29; this substance is no longer available in British sunscreens. Reflectant screens generally contain titanium dioxide or zinc oxide in cream base as active ingredients. Sunscreen substantivity varies with its hydrophilic and lipophilic properties, pH, heat stability, emollient nature, percutaneous absorptivity, ionized state and diffusion capacity30, and perhaps with ingredient adsorption and photoconjugation to stratum corneum proteins31. It may be measured by SPF assessment before and after sweating or immersion of the subject in water30, water in oil creams and alcoholic solutions being substantive and heat stable, but not oil and oil in water creams. Ammonium acrylate/ acrylate copolymer increases substantivity, but is uncomfortable on the skin32. Absorbers, except the adherent PABA and octyldimethyl PABA, little affect substantivity.
Sunscreen use is indicated for both normal and photosensitive skins during significant UVR exposure, solar UV-B being intense and damaging around midday in summer and at low latitudes and high altitudes, particularly near blue sky, white sand, rippling water or snow, even in cloudy or cool weather; solar UV-A is generally less detrimental but more constant throughout the day and with changing ambient conditions, necessitating continuing care by exposed subjects. White fluorescent lamps, emitting UV-A and a little UV-B, slightly augment the effects of sun exposure. For normal skin, UV-B screens are generally sufficient except for lengthy exposure when WV-A protection is also needed; high SPF absorbent screens (about 10-15) are usually appropriate for fair skins and medium SPF (about 5-9) or less for darker skin. Regular application' is necessary to maintain protection except with very substantive preparations. For abnormally photosensitive skin, UV-B, WJV-A or broad spectrum screens may be necessary. Responsive conditions include the UV-B-sensitive conditions xeroderma pigmentosum, albinism and vitiligo, often the UVR-exacerbated dermatoses33, predominantly UV-B sensitive, sometimes the idiopathic photodermatoses33'34 of variable action spectra, and occasionally the UV-A-sensitive chemical or drug-induced photosensitivity. Cutaneous porphyrias, induced by wavelengths around 400 nm, do not usually improve. Phototesting in some conditions, notably solar urticaria and chronic actinic dermatitis, may indicate the exact disease action spectrum and likely efficacy of a sunscreen. For UV-B-sensitive conditions, absorbent screens may be sufficient, but UV-A-sensitivity generally requires reflectant or combination absorbent/ reflectant preparations; generally high SPF screens (about 10-15) should be used. Resistant conditions in addition may require low-dose WTVR, topical or oral therapy.
Adverse effects from absorbent sunscreens include drying, transient irritation and allergic contact or photocontact dermatitis to UVR absorber, fragrance or preservative, occasionally simulating the underlying dermatosis and generally demonstrable by patch and photopatch testing. Reflectant sunscreens are often considered greasy, opaque and cosmetically unsatisfactory even if tinted toward skin colour. An alternative preparation should be used.
The exact choice of sunscreen for any purpose depends on personal preference from published lists of effective and suitable preparations35'36; satisfactory modern high protection compounds are now available for normal subjects in most circumstances. However, much scope remains for increasing protection in severe photosensitivity, augmenting cosmetic acceptability and vehicle substantivity and reducing the frequency of adverse effects. The quest for improvement must continue. G M Murphy J L M Hawk Department of Photobiology Institute ofDermatology, London
